Cresco Labs (CRLBF) Cash from Operations Growth (1y) (2020 - 2025)
Cresco Labs (CRLBF) Cash from Operations Growth (1y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 81.06% |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 8.26% |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -46.22% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 63.59% |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | 73.78% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 33.73% |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | 16.88% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Cresco Labs | 295.09 Mn | 230.98 Mn | 86.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.97% |
| Sep 30, 2025 | -87.51% |
| Dec 31, 2024 | 993.24% |
| Sep 30, 2024 | 21.52% |
| Dec 31, 2023 | -190.91% |
| Sep 30, 2023 | 58.65% |
| Dec 31, 2022 | -90.36% |
| Sep 30, 2022 | 355.55% |
| Dec 31, 2021 | 90.84% |
| Sep 30, 2021 | -81.37% |
| Mar 31, 2021 | 133.94% |
| Dec 31, 2020 | 401.18% |